Cargando…

Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles

Detalles Bibliográficos
Autores principales:	Fong, Chloe C., Spencer, Julian, Howlett-Prieto, Quentin, Feng, Xuan, Reder, Anthony T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442943/ https://www.ncbi.nlm.nih.gov/pubmed/37614975 http://dx.doi.org/10.3389/fneur.2023.1245622

Ejemplares similares

Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles
por: Fong, Chloe C., et al.
Publicado: (2023)

Increased Percentage of CD8(+)CD28(−) Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
por: Houston, Timothy W., et al.
Publicado: (2022)

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
por: Roach, Charles A., et al.
Publicado: (2021)

Vitamin D enhances responses to interferon-β in MS
por: Feng, Xuan, et al.
Publicado: (2019)

Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
por: Money, Kelli M., et al.
Publicado: (2022)

Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan
por: Kjældgaard, Anne-Lene, et al.
Publicado: (2020)

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
por: Hillert, Jan, et al.
Publicado: (2021)

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
por: Moser, Tobias, et al.
Publicado: (2022)

Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis
por: Tomas-Ojer, Paula, et al.
Publicado: (2022)

Spanish Adaptation of the Dimensional Apathy Scale (DAS) in Amyotrophic Lateral Sclerosis
por: Salas, Teresa, et al.
Publicado: (2020)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate
por: Buscarinu, Maria C., et al.
Publicado: (2021)

Corrigendum: Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy
por: Bartley, Christopher M., et al.
Publicado: (2022)

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
por: Florou, Despoina, et al.
Publicado: (2020)

Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
por: Heming, Michael, et al.
Publicado: (2023)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
por: de Sèze, Jérôme, et al.
Publicado: (2023)

Validation and cross-cultural adaptation of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15) into Spanish
por: Esteve Ríos, Antonio, et al.
Publicado: (2023)

Deep Brain Stimulation Programming 2.0: Future Perspectives for Target Identification and Adaptive Closed Loop Stimulation
por: Hell, Franz, et al.
Publicado: (2019)

German translation, cultural adaption and validation of the unidimensional self-efficacy scale for multiple sclerosis: a study protocol
por: Seebacher, Barbara, et al.
Publicado: (2019)

Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases
por: Hao, Xiao-sheng, et al.
Publicado: (2023)

Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells
por: Small, George W., et al.
Publicado: (2013)

Inhibiting microglia exacerbates the early effects of cuprizone in males in a rat model of multiple sclerosis, with no effect in females
por: Xavier, Soniya, et al.
Publicado: (2023)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay
por: Miyachi, Yukino, et al.
Publicado: (2021)

Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse models
por: Reder, Anthony T.
Publicado: (2023)

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
por: Sabatino, Joseph J., et al.
Publicado: (2019)

Consensus on early detection of disease progression in patients with multiple sclerosis
por: Meca-Lallana, José E., et al.
Publicado: (2022)

Rusty Microglia: Trainers of Innate Immunity in Alzheimer's Disease
por: Sfera, Adonis, et al.
Publicado: (2018)

Corrigendum: Clinical spectrum of tauopathies
por: Olfati, Nahid, et al.
Publicado: (2022)

Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis
por: Wang, Mengli, et al.
Publicado: (2021)

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Corrigendum: Translation, Cultural Adaptation, and Validation of the Hiligaynon Montreal Cognitive Assessment Tool (MoCA-Hil) Among Patients With X-Linked Dystonia Parkinsonism (XDP)
por: Aliling, Nicole B., et al.
Publicado: (2020)

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2021)

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis()
por: Novak, Frederik, et al.
Publicado: (2021)

Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple Sclerosis
por: Roodselaar, Jay, et al.
Publicado: (2021)

Subtypes of relapsing-remitting multiple sclerosis identified by network analysis
por: Howlett-Prieto, Quentin, et al.
Publicado: (2023)

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
por: Goodin, Douglas S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2966ss4eb9hmmgmk1c825fv5cd